Derek is responsible for identifying early stage targets, small molecules and monoclonal antibodies for our drug discovery group and the licensing of mature programmes to industry.
Derek Sheader
Latest news
-
Could heart medication or arthritis drugs be used to treat motor neuron disease?
-
Accelerating innovation to transform lung health in primary care
-
LifeArc-funded trial gives new hope for children with devastating rare genetic disorder